Literature DB >> 21438846

The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy.

Shosaku Nomura, Shinya Fujita, Ryotaro Ozasa, Takahisa Nakanishi, Michihiko Miyaji, Shinichiro Mori, Tomoki Ito, Kazuyoshi Ishii.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438846     DOI: 10.3109/09537104.2011.553970

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  11 in total

1.  Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.

Authors:  Sebastian Vogel; Madhumita Chatterjee; Katja Metzger; Oliver Borst; Tobias Geisler; Peter Seizer; Iris Müller; Andreas Mack; Susanne Schumann; Hans-Jörg Bühring; Florian Lang; Rüdiger V Sorg; Harald Langer; Meinrad Gawaz
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

Review 2.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

3.  Platelet-derived HMGB1 is a critical mediator of thrombosis.

Authors:  Sebastian Vogel; Rebecca Bodenstein; Qiwei Chen; Susanne Feil; Robert Feil; Johannes Rheinlaender; Tilman E Schäffer; Erwin Bohn; Julia-Stefanie Frick; Oliver Borst; Patrick Münzer; Britta Walker; Justin Markel; Gabor Csanyi; Patrick J Pagano; Patricia Loughran; Morgan E Jessup; Simon C Watkins; Grant C Bullock; Jason L Sperry; Brian S Zuckerbraun; Timothy R Billiar; Michael T Lotze; Meinrad Gawaz; Matthew D Neal
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

Review 4.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

Review 5.  Correlation between serum levels of high mobility group box-1 protein and pancreatitis: a meta-analysis.

Authors:  Yan Lin; Lian-Jie Lin; Yu Jin; Yong Cao; Ying Zhang; Chang-Qing Zheng; Jia-Li Liu; Sheng-Li Yang
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

Review 6.  Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.

Authors:  Austin H Nguyen; Sheila B Bhavsar; Erinn M Riley; Gabriel C Caponetti; Devendra K Agrawal
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

Review 7.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

8.  From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis.

Authors:  Stefania Mardente; Emanuela Mari; Isabella Massimi; Marco Tafani; Raffaella Guerriero; Ornella Morsilli; Fabio M Pulcinelli; Marco E Bianchi; Alessandra Zicari
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

9.  Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.

Authors:  Miyuki Ookura; Naoko Hosono; Toshiki Tasaki; Kana Oiwa; Kei Fujita; Kazuhiro Ito; Shin Lee; Yasufumi Matsuda; Mihoko Morita; Katsunori Tai; Eiju Negoro; Shinji Kishi; Hiromichi Iwasaki; Takanori Ueda; Takahiro Yamauchi
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

10.  Protective Effect of Vitis labrusca Leaves Extract on Cardiovascular Dysfunction through HMGB1-TLR4-NFκB Signaling in Spontaneously Hypertensive Rats.

Authors:  Hye Yoom Kim; Mi Hyeon Hong; Jung Joo Yoon; Dae Sung Kim; Se Won Na; Youn Jae Jang; Yun Jung Lee; Dae Gill Kang; Ho Sub Lee
Journal:  Nutrients       Date:  2020-10-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.